Intelligent Medical Objects, a provider of clinical terminology management and data quality solutions for healthcare, announced today that it has acquired Melax Technologies Inc.

Melax uses artificial intelligence (AI) and natural language processing (NLP) technologies to extract information from biomedical textual data to resolve issues. The deal looks to drive IMO’s portfolio of healthcare data services and enable IMO to expand its offerings to various segments in the healthcare market to help with problems like improving clinical and administrative workflows, clinical research and patient outcomes.

“Combining Melax Tech’s analytics and NLP capabilities with IMO’s clinical terminology and data quality platform will enable healthcare organizations to have a more comprehensive solution for both clinical operation and research,” states Ann Barnes, chief executive officer at IMO. “The acquisition will also help extend our state-of-the-art capabilities to payer, pharmaceutical, and life science companies.”